A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
King, Brett, Guttman-Yassky, Emma, Peeva, Elena, Banerjee, Anindita, Sinclair, Rodney, Pavel, Ana B., Zhu, Linda, Cox, Lori Ann, Craiglow, Brittany, Chen, Linda, Banfield, Christopher, Page, Karen, Zhang, Weidong, Vincent, Michael S.
Published in Journal of the American Academy of Dermatology (01.08.2021)
Published in Journal of the American Academy of Dermatology (01.08.2021)
Get full text
Journal Article
Role of Innate Immunity in Allergic Contact Dermatitis: An Update
Yamaguchi, Hiroki L, Yamaguchi, Yuji, Peeva, Elena
Published in International journal of molecular sciences (01.08.2023)
Published in International journal of molecular sciences (01.08.2023)
Get full text
Journal Article
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Yamaguchi, Hiroki L, Yamaguchi, Yuji, Peeva, Elena
Published in International journal of molecular sciences (01.04.2024)
Published in International journal of molecular sciences (01.04.2024)
Get full text
Journal Article
A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
Xi, Li, Garcet, Sandra, Ye, Zhan, Hung, Kenneth, Hassan-Zahraee, Mina, Kieras, Elizabeth, Krueger, James G., Hyde, Craig, Peeva, Elena
Published in Scientific reports (17.11.2022)
Published in Scientific reports (17.11.2022)
Get full text
Journal Article
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Cohen, Stanley, Beebe, Jean S, Chindalore, Vishala, Guan, Shunjie, Hassan-Zahraee, Mina, Saxena, Madhurima, Xi, Li, Hyde, Craig, Koride, Sarita, Levin, Robert, Lubaczewski, Shannon, Salganik, Mikhail, Sloan, Abigail, Stevens, Erin, Peeva, Elena, Vincent, Michael S, Martin, David A, Chu, Myron
Published in Arthritis research & therapy (06.06.2024)
Published in Arthritis research & therapy (06.06.2024)
Get full text
Journal Article
Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis
Danto, Spencer I, Tsamandouras, Nikolaos, Reddy, Padma, Gilbert, Steven A, Mancuso, Jessica Y, Page, Karen, Beebe, Jean S, Peeva, Elena, Vincent, Michael S
Published in Allergy, asthma, and clinical immunology (30.08.2024)
Published in Allergy, asthma, and clinical immunology (30.08.2024)
Get full text
Journal Article
Natural History of Keloids: A Sociodemographic Analysis Using Structured and Unstructured Data
Swenson, Anna, Paulus, Jessica K., Jung, Yoojin, Weiss, Stefan, Berman, Brian, Peeva, Elena, Yamaguchi, Yuji, George, Prethibha, Jagun, Oladayo
Published in Dermatology and therapy (01.01.2024)
Published in Dermatology and therapy (01.01.2024)
Get full text
Journal Article
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
Singh, Ravi Shankar P., Pradhan, Vivek, Roberts, Erika S., Scaramozza, Matthew, Kieras, Elizabeth, Gale, Jeremy D., Peeva, Elena, Vincent, Michael S., Banerjee, Anindita, Fensome, Andrew, Dowty, Martin E., Winkle, Peter, Tehlirian, Christopher
Published in Clinical and translational science (01.03.2021)
Published in Clinical and translational science (01.03.2021)
Get full text
Journal Article
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
King, Brett, Guttman-Yassky, Emma, Peeva, Elena, Banerjee, Anindita, Zhu, Linda, Zhu, Hua, Cox, Lori Ann, Vincent, Michael S., Sinclair, Rodney
Published in JID innovations (01.11.2022)
Published in JID innovations (01.11.2022)
Get full text
Journal Article
B-Cell-Directed Therapies in Systemic Lupus Erythematosus
Tieng, Arlene T., MD, Peeva, Elena, MD, MSc
Published in Seminars in arthritis and rheumatism (01.12.2008)
Published in Seminars in arthritis and rheumatism (01.12.2008)
Get full text
Journal Article
33304 Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, shows efficacy in patients with active nonsegmental vitiligo and either a lighter or darker Fitzpatrick skin type: Results from a phase 2b, randomized, dose-ranging study with an extension period
Peeva, Elena, Yamaguchi, Yuji, King, Brett
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
33300 Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes repigmentation of stable lesions in patients with active nonsegmental vitiligo: Results from a phase 2b, randomized, placebo-controlled, dose-ranging study
Yamaguchi, Yuji, Peeva, Elena, Shore, Ronald
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
Gender and autoimmunity
Zandman-Goddard, Gisele, Peeva, Elena, Shoenfeld, Yehuda
Published in Autoimmunity reviews (01.06.2007)
Published in Autoimmunity reviews (01.06.2007)
Get full text
Journal Article
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial
Gooderham, Melinda J, Forman, Seth B, Bissonnette, Robert, Beebe, Jean S, Zhang, Weidong, Banfield, Chris, Zhu, Linda, Papacharalambous, Jocelyne, Vincent, Michael S, Peeva, Elena
Published in JAMA dermatology (Chicago, Ill.) (01.12.2019)
Published in JAMA dermatology (Chicago, Ill.) (01.12.2019)
Get more information
Journal Article